» Articles » PMID: 34384539

Towards a European Strategy to Address the COVID-19 Pandemic

Citing Articles

Measuring influencing factors affecting mortality rates during the COVID-19 pandemic.

Wu J, Huang K Glob Health Action. 2024; 17(1):2428067.

PMID: 39530400 PMC: 11559029. DOI: 10.1080/16549716.2024.2428067.


Efficacy of adjuvant-associated COVID-19 vaccines against SARS-CoV-2 variants of concern in randomized controlled trials: A systematic review and meta-analysis.

Cheng M, Weng Z, Li R, Song G Medicine (Baltimore). 2024; 103(7):e35201.

PMID: 38363919 PMC: 10869057. DOI: 10.1097/MD.0000000000035201.


Development of an eLearning intervention for enhancing health professionals' skills for addressing COVID-19 vaccine hesitancy.

Papadakis S, Anastasaki M, Gamaletsou M, Papagiannopoulou X, Aligizakis E, Lionis C Front Med (Lausanne). 2023; 10:1290288.

PMID: 38155659 PMC: 10753786. DOI: 10.3389/fmed.2023.1290288.


Differences in non-positive intention to accept the COVID-19 booster vaccine between three countries in the cross-border region Meuse-Rhine Euroregion: The Netherlands, Belgium, and Germany.

van Bilsen C, Stabourlos C, Moonen C, Brinkhues S, Demarest S, Hanssen D Vaccine X. 2023; 14:100306.

PMID: 37113740 PMC: 10116119. DOI: 10.1016/j.jvacx.2023.100306.


The impact of the COVID-19 pandemic on the Mediterranean region over 18 months: bridging the health outcomes and sustainable development goals.

Cuschieri S, Grech E, Gatt A, Cutajar A, Vassallo C, Zahra D Afr Health Sci. 2023; 22(4):551-564.

PMID: 37113533 PMC: 10126880. DOI: 10.4314/ahs.v22i4.61.


References
1.
Priesemann V, Balling R, Brinkmann M, Ciesek S, Czypionka T, Eckerle I . An action plan for pan-European defence against new SARS-CoV-2 variants. Lancet. 2021; 397(10273):469-470. PMC: 7825950. DOI: 10.1016/S0140-6736(21)00150-1. View

2.
Phelan A . COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges. Lancet. 2020; 395(10237):1595-1598. PMC: 7198144. DOI: 10.1016/S0140-6736(20)31034-5. View

3.
Contreras S, Dehning J, Loidolt M, Zierenberg J, Spitzner F, Urrea-Quintero J . The challenges of containing SARS-CoV-2 via test-trace-and-isolate. Nat Commun. 2021; 12(1):378. PMC: 7810722. DOI: 10.1038/s41467-020-20699-8. View

4.
Iftekhar E, Priesemann V, Balling R, Bauer S, Beutels P, Valdez A . A look into the future of the COVID-19 pandemic in Europe: an expert consultation. Lancet Reg Health Eur. 2021; 8:100185. PMC: 8321710. DOI: 10.1016/j.lanepe.2021.100185. View

5.
Krueger T, Gogolewski K, Bodych M, Gambin A, Giordano G, Cuschieri S . Risk assessment of COVID-19 epidemic resurgence in relation to SARS-CoV-2 variants and vaccination passes. Commun Med (Lond). 2022; 2:23. PMC: 9053266. DOI: 10.1038/s43856-022-00084-w. View